Biomea Fusion Inc. (BMEA)
BMEA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.26
-7.35% on the day
Market cap
$91.3M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | BMEA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001840439 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-22 |
| Latest annual report | 10-K | 2026-03-24 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEF 14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 290 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RTSN | Retension Pharmaceuticals Inc. | $11.63 | +2.74% | $91.7M |
| CRBP | Corbus Pharmaceuticals Holdings Inc. | $4.78 | -9.30% | $92.5M |
| ANIX | Anixa Biosciences Inc. | $2.67 | -5.99% | $92.8M |
| RLYB | Rallybio Corporation | $16.72 | -0.42% | $88.8M |
| IMUX | Immunic Inc. | $6.89 | -13.33% | $94.0M |
| AARD | Aardvark Therapeutics Inc. | $4.04 | -9.21% | $88.4M |
| OKUR | OnKure Therapeutics Inc. | $2.35 | -3.10% | $95.0M |
| MIST | Milestone Pharmaceuticals Inc. Common Shares | $0.7658 | -4.93% | $95.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier